Loading...
•
Dec 31, 2019
Perrigo Q4 2019 Earnings Report
Perrigo's Q4 2019 earnings were released, highlighted by record consumer self-care Americas net sales and progress in transforming into a consumer self-care company.
Key Takeaways
Perrigo reported a 10.7% increase in consolidated net sales to $1.3 billion for Q4 2019, driven by increased demand, the addition of Ranir, and new product sales. Adjusted diluted EPS increased 9.3% to $1.06.
Consolidated net sales increased by 10.7% to $1.3 billion.
Consumer Self-Care Americas achieved record fourth quarter reported net sales of $711 million, a 15.2% increase.
Reported diluted loss per share was $0.14, compared to earnings per share of $0.60 in the prior year quarter.
Adjusted diluted EPS increased 9.3% to $1.06.
Revenue by Segment
Forward Guidance
Perrigo expects fiscal 2020 net sales growth of 6% to 7%, with organic net sales growth of approximately 3%. Adjusted diluted EPS is expected to be between $3.95 to $4.15, which includes $50 million in transformational investments.
Positive Outlook
- Expects net sales growth of approximately 6% to 7%.
- Expects organic net sales growth of approximately 3%.
- Adjusted diluted EPS is expected to be between $3.95 to $4.15.
- Continuing to make necessary investments in the business.
- Setting the stage for 5% adjusted operating profit growth in Year 3.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...